News

COVID-19

Kimberly Redmond | Equities.com |

The number of Americans filing new claims for unemployment benefits dropped to a 19-month low last week, the US Labor Department reported Thursday.

First-time filings for unemployment benefits totaled 290,000 for the week ending Oct. 16, down 6,000 from the previous week. It marks the second week in a row that claims fell below 300,000.


Kimberly Redmond | Equities.com |

The US Food and Drug Administration (FDA) signed off Wednesday on extending COVID-19 boosters to the millions of Americans who received the Moderna Inc (Nasdaq: MRNA) or Johnson & Johnson (NYSE: JNJ) vaccines and said anyone eligible for an extra shot can mix and match doses from different drug providers.

Specifically, regulators amended the emergency use authorizations to permit a half dose of Moderna’s vaccine as a booster shot for seniors and others at high risk from the virus six months after their last shot.


Kimberly Redmond | Equities.com |

Drugmaker Merck & Co Inc (NYSE: MRK) and its partner Ridgeback Biotherapeutics LP announced Monday that they have requested an emergency use authorization from the US Food and Drug Administration (FDA) for their oral antiviral COVID-19 treatment.

If approved, the pill, molnupiravir, would be the first oral therapy for COVID-19 and could be a potential breakthrough on how the virus is treated since all other FDA-backed treatments require an injection or IV.


Kimberly Redmond | Equities.com |

United Airlines Inc (NYSE: UAL) announced Thursday plans to ramp up its December schedule to 3,500 domestic flights per day, the most its flown in the US since the COVID-19 pandemic began.

In anticipation of a strong holiday travel season, the Chicago-based carrier said it will boost its schedule on popular winter routes, particularly warm weather destinations and ski hot spots.


Kimberly Redmond | Equities.com |

International Business Machines Corporation (NYSE: IBM) says all US-based employees must be fully vaccinated against COVID-19 by Dec. 8 or face unpaid suspension.

The Armonk, New York-based tech giant told workers last week that, as a government contractor, it must comply with the Biden administration’s vaccine mandate for large companies, federal workers and federal contractors, CNBC reported Thursday, citing an internal memo.


Kimberly Redmond | Equities.com |

Pfizer Inc (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced Thursday they have asked the US Food and Drug Administration (FDA) to expand their COVID-19 vaccine’s emergency use authorization to cover children ages five to 11.

If authorized, this would be the first coronavirus vaccine authorized for younger children. Currently, the Pfizer-BioNTech shots are only approved in the US for people ages 16 and up and in the EU for people ages 12 to 15.


AP News | Equities.com |

The Centers for Disease Control and Prevention on Thursday endorsed booster shots for millions of older or otherwise vulnerable Americans, opening a major new phase in the U.S vaccination drive against COVID-19.

CDC Director Dr. Rochelle Walensky signed off on a series of recommendations from a panel of advisers late Thursday.


Kimberly Redmond | Equities.com |

The ongoing semiconductor shortage is now expected to cost the global automotive industry $210 billion in revenue this year, according to global consulting firm AlixPartners.

The forecast released Thursday is almost double the firm's previous projection of $110 billion made in May.


Kimberly Redmond | Equities.com |

Food delivery service DoorDash Inc (NYSE: DASH) will now support delivery of beer, wine and spirits across 20 US states, the District of Columbia, Canada and Australia, a move the company said could enable it to reach 100 million+ customers.

In a press release Monday, DoorDash said customers of legal age can toggle to the alcohol tab of its app to order drinks from a selection of restaurants, grocery stores, convenience stores and local retailers in markets that permit alcohol delivery.


Kimberly Redmond | Equities.com |

CVS Health Corporation (NYSE: CVS) plans to fill as many as 25,000 clinical and retail jobs nationwide ahead of the flu season and as the US prepares to roll out COVID-19 booster shots.

On Monday, the largest pharmacy chain by number of stores said that most of the openings are for temporary, full-time and part-time licensed pharmacists, trained pharmacy technicians, nurses and retail workers.